An Open-Label, Multiple-Dose, Randomized, Crossover Study In Healthy Volunteers To Investigate The Pharmacokinetics Of Three Dose Strengths Of Pregabalin Controlled Release Formulations Administered Following An Evening Meal As Compared To The Immediate Release Formulation.

Trial Profile

An Open-Label, Multiple-Dose, Randomized, Crossover Study In Healthy Volunteers To Investigate The Pharmacokinetics Of Three Dose Strengths Of Pregabalin Controlled Release Formulations Administered Following An Evening Meal As Compared To The Immediate Release Formulation.

Completed
Phase of Trial: Phase I

Latest Information Update: 30 Dec 2009

At a glance

  • Drugs Pregabalin (Primary)
  • Indications Epilepsy; Fibromyalgia; Generalised anxiety disorder; Neuropathic pain; Pain; Postherpetic neuralgia; Postoperative pain; Restless legs syndrome
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 30 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 11 Dec 2009 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 10 Nov 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top